BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3122596)

  • 1. Clinical pharmacokinetics of long-term infusion of midazolam in critically ill patients--preliminary results.
    Dirksen MS; Vree TB; Driessen JJ
    Anaesth Intensive Care; 1987 Nov; 15(4):440-4. PubMed ID: 3122596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of midazolam administered by continuous intravenous infusion to intensive care patients.
    Malacrida R; Fritz ME; Suter PM; Crevoisier C
    Crit Care Med; 1992 Aug; 20(8):1123-6. PubMed ID: 1643892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of long-term sufentanil infusion for sedation in ICU patients.
    Ethuin F; Boudaoud S; Leblanc I; Troje C; Marie O; Levron JC; Le Moing JP; Assoune P; Eurin B; Jacob L
    Intensive Care Med; 2003 Nov; 29(11):1916-20. PubMed ID: 12923616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Midazolam infusion for basal sedation in intensive care: absence of accumulation.
    Michalk S; Moncorge C; Fichelle A; Huot O; Servin F; Farinotti R; Desmonts JM
    Intensive Care Med; 1988; 15(1):37-41. PubMed ID: 3230199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative population pharmacokinetics of lorazepam and midazolam during long-term continuous infusion in critically ill patients.
    Swart EL; Zuideveld KP; de Jongh J; Danhof M; Thijs LG; Strack van Schijndel RM
    Br J Clin Pharmacol; 2004 Feb; 57(2):135-45. PubMed ID: 14748812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Continuous infusion of ketamine and midazolam for prolonged sedation in the intensive care unit].
    Kawamata M; Ujike Y; Miyabe M; Kobayashi I; Arakawa J; Namiki A; Imaizumi H; Yamaya K
    Masui; 1991 Dec; 40(12):1793-8. PubMed ID: 1770572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetics and metabolism of midazolam in pediatric intensive care patients.
    de Wildt SN; de Hoog M; Vinks AA; van der Giesen E; van den Anker JN
    Crit Care Med; 2003 Jul; 31(7):1952-8. PubMed ID: 12847388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of acute changes in renal function on the pharmacokinetics of midazolam during long-term infusion in ICU patients.
    Driessen JJ; Vree TB; Guelen PJ
    Acta Anaesthesiol Belg; 1991; 42(3):149-55. PubMed ID: 1767626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of midazolam during continuous infusion in critically ill neonates.
    Jacqz-Aigrain E; Daoud P; Burtin P; Maherzi S; Beaufils F
    Eur J Clin Pharmacol; 1992; 42(3):329-32. PubMed ID: 1577053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of midazolam and its main metabolite 1-hydroxymidazolam in intensive care patients.
    Boulieu R; Lehmann B; Salord F; Fisher C; Morlet D
    Eur J Drug Metab Pharmacokinet; 1998; 23(2):255-8. PubMed ID: 9725490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased plasma albumin concentration results in increased volume of distribution and decreased elimination of midazolam in intensive care patients.
    Vree TB; Shimoda M; Driessen JJ; Guelen PJ; Janssen TJ; Termond EF; van Dalen R; Hafkenscheid JC; Dirksen MS
    Clin Pharmacol Ther; 1989 Nov; 46(5):537-44. PubMed ID: 2582710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing circadian rhythms during prolonged midazolam infusion in the pediatric intensive care unit (PICU) children.
    Bienert A; Bartkowska-Sniatkowska A; Wiczling P; Rosada-Kurasińska J; Grześkowiak M; Zaba C; Teżyk A; Sokołowska A; Kaliszan R; Grześkowiak E
    Pharmacol Rep; 2013; 65(1):107-21. PubMed ID: 23563029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and pharmacodynamics of midazolam given via continuous intravenous infusion in intensive care units.
    Fragen RJ
    Clin Ther; 1997; 19(3):405-19; discussion 367-8. PubMed ID: 9220206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacokinetics of midazolam in intensive care patients, a wide interpatient variability?
    Oldenhof H; de Jong M; Steenhoek A; Janknegt R
    Clin Pharmacol Ther; 1988 Mar; 43(3):263-9. PubMed ID: 3345618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics and EEG effects of midazolam during and after 1-minute, 1-hour, and 3-hour intravenous infusions.
    Greenblatt DJ; Ehrenberg BL; Culm KE; Scavone JM; Corbett KE; Friedman HL; Harmatz JS; Shader RI
    J Clin Pharmacol; 2004 Jun; 44(6):605-11. PubMed ID: 15145968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Total intravenous anesthesia with continuous infusion of midazolam--study on plasma levels of midazolam and catecholamines].
    Nishiyama T; Odaka Y; Seto K
    Masui; 1990 Oct; 39(10):1383-7. PubMed ID: 2255046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous infusion of midazolam in the treatment of refractory generalized convulsive status epilepticus.
    Ulvi H; Yoldas T; Müngen B; Yigiter R
    Neurol Sci; 2002 Oct; 23(4):177-82. PubMed ID: 12536286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term propofol infusion as an adjunct to extubation in burned children.
    Sheridan RL; Keaney T; Stoddard F; Enfanto R; Kadillack P; Breault L
    J Burn Care Rehabil; 2003; 24(6):356-60. PubMed ID: 14610418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacodynamic modelling of lorazepam- and midazolam-induced sedation upon long-term continuous infusion in critically ill patients.
    Swart EL; Zuideveld KP; de Jongh J; Danhof M; Thijs LG; Strack van Schijndel RM
    Eur J Clin Pharmacol; 2006 Mar; 62(3):185-94. PubMed ID: 16425056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Midazolam for sedation in the paediatric intensive care unit.
    Rosen DA; Rosen KR
    Intensive Care Med; 1991; 17 Suppl 1():S15-9. PubMed ID: 1774407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.